GlassScriptPhysician profile
Bridget Hillman
NPI 1174520886
$2,486.56
in general payments reported to CMS, 2019-2025
28 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,473 · 2022: $769 · 2023: $44.38 · 2024: $43.86 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $244.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $445.99 | 2021-2025 | |
| Amgen INC. | $252.95 | 2021-2022 | |
| Lilly USA, LLC | $234.21 | 2021-2022 | |
| Novo Nordisk INC | $221.80 | 2021-2025 | Rybelsus, Ozempic |
| Sanofi-Aventis U.S. LLC | $151.22 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $128.84 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $124.92 | 2021-2022 | |
| Astellas Pharma US INC | $117.06 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $116.70 | 2021-2022 | |
| Pfizer INC. | $101.86 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.91 | 2021-2022 | |
| Abbott Laboratories | $81.62 | 2022-2024 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $64.58 | 2022-2023 | |
| Horizon Therapeutics Plc | $48.61 | 2021-2022 | |
| Glaxosmithkline, LLC. | $37.63 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $32.73 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $31.81 | 2021 | |
| Daiichi Sankyo INC. | $28.20 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.88 | 2022 | |
| Exact Sciences Corporation | $20.36 | 2025 | The Cologuard Plus Collection Kit |
| Biohaven Pharmaceuticals, INC. | $18.57 | 2021 | |
| Esperion Therapeutics, INC. | $18.26 | 2022 | |
| Axsome Therapeutics, INC. | $15.78 | 2025 | Auvelity |
| Genentech USA, INC. | $15.44 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.21 | 2022 | |
| Merck Sharp & Dohme LLC | $15.11 | 2022 | |
| Amarin Pharma, INC. | $14.61 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $12.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Hillman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.